Physician profile
Stephen S Baker
NPI 1528056785
$20,204.03
in general payments reported to CMS, 2019-2025
46 companies · $403 in 2025
The $403 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2020: $558 · 2021: $372 · 2022: $531 · 2023: $488 · 2024: $209 · 2025: $403.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,099.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,099.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $17,317.00 | 2019-2022 | |
| Myriad Genetic Laboratories, INC. | $611.49 | 2021-2025 | Myrisk, Prolaris |
| Coloplast Corp | $438.05 | 2019-2025 | |
| Janssen Biotech, INC. | $205.36 | 2019-2020 | |
| Astellas Pharma US INC | $154.08 | 2020-2023 | Myrbetriq |
| Endo Pharmaceuticals INC. | $120.94 | 2019-2022 | |
| Olympus America INC. | $116.97 | 2020-2023 | Itind System |
| Boston Scientific Corporation | $105.56 | 2019-2022 | |
| C. R. Bard, INC. & Subsidiaries | $75.67 | 2020 | |
| Novartis Pharmaceuticals Corporation | $65.31 | 2022-2023 | |
| Endo USA, INC. | $57.70 | 2025 | Xiaflex |
| Integra Lifesciences Corporation | $56.01 | 2019 | |
| Dendreon Pharmaceuticals LLC | $53.51 | 2023-2025 | Provenge |
| Bayer Healthcare Pharmaceuticals INC. | $49.28 | 2022-2025 | |
| Verity Pharmaceuticals INC. | $44.60 | 2023-2024 | Trelstar |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $43.43 | 2023-2025 | Orgovyx, Gemtesa |
| Abbvie INC. | $42.54 | 2022-2023 | Botox |
| Tolmar, INC. | $42.39 | 2023-2024 | |
| Karl Storz Endoscopy-America | $37.90 | 2019 | |
| Axonics, INC. | $37.20 | 2023-2024 | Axonics |
| Procept Biorobotics Corporation | $36.15 | 2021-2025 | |
| Ferring Pharmaceuticals INC. | $34.40 | 2025 | Adstiladrin |
| Antares Pharma, INC. | $32.45 | 2022-2023 | Tlando, Xyosted, Nocdurna |
| Urogen Pharma, INC. | $31.82 | 2022-2025 | |
| Urovant Sciences INC | $30.20 | 2022 | |
| Teleflex LLC | $26.76 | 2021 | |
| Civco Medical Instruments | $24.18 | 2025 | |
| Becton, Dickinson and Company | $23.27 | 2025 | Bard Urinary Drainage Bag |
| Immunitybio, INC. | $22.42 | 2025 | |
| Ambu INC. | $20.19 | 2020 | |
| Accord Healthcare, INC. | $18.89 | 2022 | |
| Edap Technomed INC | $18.42 | 2020 | |
| Tolmar Pharmaceuticals, INC. | $18.20 | 2021 | |
| Medtronic, INC. | $18.04 | 2023 | Interstim |
| Neotract INC. | $17.58 | 2019 | |
| Metuchen Pharmaceuticals | $17.57 | 2020 | |
| Calyxo, INC. | $15.92 | 2025 | Cvac Aspiration System |
| Angiodynamics, INC. | $15.38 | 2023 | Nanoknife |
| Pfizer INC. | $15.19 | 2019 | |
| Alnylam Pharmaceuticals INC. | $15.11 | 2022 | |
| Smith+Nephew, INC. | $14.99 | 2019 | |
| Azurity Pharmaceuticals, INC. | $14.72 | 2025 | Azmiro |
| Merck Sharp & Dohme LLC | $14.54 | 2022 | |
| Bioprotect Medical, INC. | $14.00 | 2024 | Bioprotect Balloon Implant System |
| Dornier Medtech America, INC | $12.90 | 2020 | |
| Clarus Therapeutics INC. | $5.75 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.